New Bill Could Open Major Exchanges to Cannabis Companies

A new congressional bill introduced this week targets one of the cannabis industry's most persistent financial barriers by proposing to eliminate restrictions that prevent marijuana companies from listing on major U.S. stock exchanges. The legislation would allow cannabis businesses to access the New York Stock Exchange and NASDAQ, currently off-limits due to federal prohibition, even as these companies operate legally under state frameworks.

The move addresses a critical capital formation bottleneck that has forced cannabis companies onto smaller exchanges like the Canadian Securities Exchange or over-the-counter markets, where liquidity remains limited and institutional participation stays minimal. Major pension funds, mutual funds, and other institutional investors typically avoid OTC-listed cannabis stocks due to compliance restrictions and federal illegality concerns, constraining the sector's access to the estimated $50 trillion in institutional assets under management.

Cannabis companies currently trade at significant discounts to traditional consumer goods and pharmaceutical peers, with enterprise value-to-revenue multiples averaging 2-4x compared to 6-8x for comparable sectors. Access to major exchanges could compress these valuation gaps by expanding the investor base and improving trading liquidity. Companies like Curaleaf, Green Thumb Industries, and Trulieve, which collectively generate over $4 billion in annual revenue, could see immediate re-rating benefits from enhanced institutional accessibility.

The timing aligns with broader federal cannabis reform momentum, including ongoing discussions around banking legislation and potential rescheduling initiatives. However, the bill faces the same political headwinds that have stalled previous reform efforts, particularly in a divided Congress where cannabis policy remains contentious. The legislation would need to navigate complex regulatory coordination between the Securities and Exchange Commission, which oversees exchange listings, and federal agencies that enforce drug prohibition.

Market participants view exchange access as potentially transformative for sector fundamentals, beyond just stock price impacts. Major exchange listings typically require enhanced financial reporting standards and corporate governance practices, which could accelerate industry professionalization and attract higher-quality management teams. The development represents another step toward normalizing cannabis as an investment category, though implementation timelines remain uncertain given the legislative process and regulatory complexity involved.